Position in AZN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$15,411,554
-$129,775 QoQ
Shares Held
81,276
+3.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#255
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Chesley Taft & Associates LLC holds $123,067,788 across 10 Drug Manufacturers - General names. AZN ranks #3 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
209,735 | $53,266,397 | |
| 2 | LLY |
ELI LILLY & Co
|
20,347 | $24,404,803 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
81,276 | $15,411,554 | |
| 4 | MRK |
Merck & Co., Inc.
|
55,810 | $7,171,585 | |
| 5 | AMGN |
Amgen Inc
|
18,897 | $6,842,981 | |
| 6 | NVS |
Novartis AG
|
32,410 | $5,079,295 | |
| 7 | ABBV |
AbbVie Inc.
|
19,924 | $5,013,674 | |
| 8 | PFE |
Pfizer Inc
|
194,317 | $4,679,152 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,411,554 | 81,276 | Shares | Other | 2026-07-08 | |
| 2026-03-31 | $15,541,329 | 78,802 | Shares | Other | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||